Neurological disorders
In this section you will find Therapeutics Diseases & Conditions Neurological disorders market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Biomarkers in Alzheimer's Disease, 2011
Published by BioPharm Reports on Feb 23rd, 2011Regular Price: €1,842.00
Special Price: €1,659.00
This report brings together the latest advances in the identification of AD biomarkers and analyses the opportunities they offer in drug R&D and diagnostics. Learn More -
Image-Based Biomarkers in Alzheimer's Disease, 2011
€452.00Published by BioPharm Reports on Feb 22nd, 2011This report provides an overview of image-based biomarkers associated with Alzheimer’s disease (AD), that have potential in differential diagnosis, in following treatment, in clinical trials and drug discovery. AD... Learn More -
Biomarkers in Parkinson's Disease, 2011
€1,675.00Published by BioPharm Reports on Jan 17th, 2011This report presents a comprehensive update on PD biomarker developments up to 2010. It covers the major classes of emerging and new markers relating to PD (blood, CSF, metabolomic, image... Learn More -
CNS Clinical Trials: World Market Prospects 2011-2026
€1,799.00Published by Visiongain on Dec 13th, 2010where you can find growth opportunities in that sector How will the CNS clinical trials sector develop from 2010, and where can you find the greatest opportunities there? Our new... Learn More -
Neurodegenerative Diseases: World Drug Market 2011-2026
€1,799.00Published by Visiongain on Nov 2nd, 2010how you can find demand and revenue trends there Would you like to know how the industry and market for neurodegenerative drug treatments will develop? There will be trends to... Learn More -
Alzheimer’s Disease Immunotherapy Pipeline: Vaccines, Therapeutic Antibodies and Emerging Strategies
€1,743.00Published by BioPharm Reports on Jul 16th, 2010Current drug treatments for Alzheimer’s Disease (AD) are dominated by two drug classes: the cholinesterase inhibitors (e.g. Aricept®) and, more recently, an NMDA receptor antagonist (e.g. Ebixa®). While these drugs... Learn More -
Neuropathic Pain: Competing Treatments and Market Entry Considerations
€7,190.00Published by BioPharm Reports on Jun 1st, 2010This report presents the findings of a global study of current therapeutic approaches to the treatment of Neuropathic Pain (NP). These findings were made following the participation of more than... Learn More -
Stroke: Competing Treatments and Market Entry Considerations 2010
€7,190.00Published by BioPharm Reports on Jun 1st, 2010This report presents the findings of a global survey on current treatments and prescribing practices for Ischaemic Stroke, Haemorrhagic Stroke and Transient Ischaemic Attack (TIA). These findings were made following... Learn More -
Alzheimer's Disease: Current Treatment Practices and Opportunities 2010
€3,400.00Published by BioPharm Reports on Feb 22nd, 2010This report presents the findings of a comprehensive survey of current clinical practices in the treatment of Alzheimer’s Disease (AD). Learn More -
Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential
€2,691.00Published by Kalorama Information on Feb 1st, 2010Stimulation of muscles and nerves by the use of electrical stimulation, notably TENS and EMS, has long been part of pain management. But recent developments, such as implanted technologies and... Learn More -
World Sleep Disorders Market Analysis 2009-2024
€1,739.00Published by Visiongain on Jun 18th, 2009Sleep disorders affect hundreds of millions of people worldwide. It is a multi-billion dollar market for drug-based treatments with continuing potential for growth. Learn More -
Alzheimers Disease: Markets, Pipeline and Opportunities 2009
€1,842.00Published by BioPharm Reports on Apr 21st, 2009This report gives a comprehensive overview of the market performance of approved AD drugs, globally, regionally and in the US. The current pipeline, drug development strategies and opportunities in this field are also reviewed.
Learn More -
Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking
€2,890.00Published by TriMark Publications LLC on Mar 1st, 2009In examining the troubling increase in a variety of sleep disorders, this report will analyze the causes and available treatments for sleep disorder sufferers. Learn More -
Sleep Disorders Market Analysis 2008-2018
€1,739.00Published by Visiongain on Mar 25th, 2008The market penetration for insomnia drugs has not reached saturation point. Opportunities remain. But with the introduction of several new products the market is set to see changes, but expansion. This expansion is based on increased general awareness physicians better comprehension of the significance of this disease and the positive role that a sleep medication prescription plays. Learn More -
The Antipsychotics Market Insight & Analysis 2008
€1,739.00Published by Visiongain on Feb 19th, 2008This in-depth market analysis examines prospects for antipsychotic drugs right through to 2012, including sales forecasts for leading products. Learn More